.png)
Healthtech
RXNT Lands on TIME’s 2025 World’s Top HealthTech Companies List
The TIME Recognition Strategy
Society22 identified TIME's inaugural HealthTech ranking early and built a comprehensive submission strategy that emphasized:
RXNT's financial stability and growth trajectory
Strong market reputation scores backed by client testimonials and review platform data
Consumer engagement metrics demonstrating platform adoption and satisfaction
Recent media coverage and thought leadership establishing industry authority
The Proprietary Survey Approach
Society22 developed and fielded an original survey on ambulatory care provider challenges, which:
Generated exclusive data points unavailable to competitors
Provided newsworthy statistics that attracted journalist interest
Positioned RXNT as a research-backed authority on provider pain points
Created multiple story angles across a six-month period
The Newsjacking Playbook
When major healthcare policy changes or industry news broke, Society22:
Rapidly developed RXNT executive commentary within 2-4 hours
Pitched targeted responses to journalists covering the story
Connected RXNT's solutions to trending conversations
Secured 12+ placements through timely, relevant commentary
THE
CHALLENGE
Despite offering robust, ONC-certified EHR and billing solutions with high client satisfaction scores, RXNT faced three critical barriers to growth:
Limited Market Visibility: Large provider networks and major health systems were overlooking RXNT's platform because its media presence didn't match its innovation or track record.
Enterprise Access: Decision-makers at scale weren't aware of RXNT's differentiated offerings, making it difficult to secure meetings and close deals with high-value prospects.
Competitive Disadvantage: In a crowded healthtech landscape where reputation and third-party validation drive enterprise relationships, RXNT lacked the "top-of-mind" status needed to compete for major contracts.
As RXNT's Chief Marketing Officer, Andrew Speight noted, the company needed to break through industry noise and establish authority with the enterprise buyers who could deliver transformative growth.
THE SOCIETY22
APPROACH
Society22 PR designed a comprehensive ongoing campaign focused on three core pillars:
Strategic Media Relations
Secured targeted placements in leading healthcare trade publications and business media
Developed high-impact press releases highlighting product innovation, AI-powered features, and client outcomes
Implemented real-time newsjacking to insert RXNT into trending healthcare conversations
Conducted ongoing competitive media analysis to identify white space opportunities
Executive Thought Leadership
Positioned CEO Randy Boldyga and the product team for interviews with top-tier outlets
Coordinated speaking engagements at influential healthcare conferences
Created proprietary survey content on care trends to generate owned media angles
Developed byline articles and commentary on healthcare IT policy and innovation
Awards & Recognition Strategy
Systematically nominated RXNT for industry awards and analyst rankings
Prepared detailed submissions emphasizing RXNT's differentiation for larger provider groups
Targeted TIME's World's Top HealthTech Companies analysis through strategic outreach and positioning
Leveraged each recognition to generate additional earned media coverage
THE
RESULTS
Major Recognition
TIME's World's Top HealthTech Companies 2025: RXNT achieved "Very High" performance among all U.S. Health Information & Management firms, ranking among just 94 companies nationwide and 400 globally. This recognition validated RXNT's impact across financial performance, market reputation, and consumer engagement.
Media Impact
89 secured placements across digital, broadcast, and podcast channels
152M combined readership across all coverage
$9.9M advertising value equivalency earned through media exposure
175% increase in news and PR coverage compared to the prior 12-month period
Two televised segments featuring RXNT's executive team on regional business programs
Digital Authority
11% increase in organic website traffic
81 high-quality backlinks earned from authoritative publications
Google-indexed placements in major outlets, including Entrepreneur and Medical Economics, improving search visibility for key terms
3% share of voice increase in a highly competitive market sector
Business Development Support
Measurable uptick in enterprise inquiries from multi-state provider organizations
Third-party credibility from TIME and analyst recognition strengthened positioning in high-stakes RFPs
More than 60 awards secured from market research firms, analyst companies, and review platforms
"Last week, I was looking through the first few pages of our search results and saw a handful of those indexed coverage pieces; I noticed a local business spotlight, and the Empowered Patient Podcast was one from Society22 as well. It was great!"
— Andrew Speight, Chief Marketing Officer, RXNT
The Impact
RXNT's partnership with Society22 PR demonstrates how strategic communications can transform market positioning for B2B technology companies. By systematically building visibility, credibility, and thought leadership, RXNT evolved from a well-regarded but under-recognized platform to a TIME-honored industry leader capturing enterprise attention.
The campaign's success wasn't about a single tactic—it was about sustained execution across media relations, thought leadership, and strategic recognition. For healthtech companies struggling to break through at the enterprise level, RXNT's journey proves that reputation and visibility aren't "nice-to-haves"—they're essential growth drivers that directly impact business development success.
Ready to turn your growth story into strategic visibility? Contact Society22 PR to explore how we can amplify your next chapter. www.society22pr.com or info@society22pr.com